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http:WHAT THIS PAPER ADDS
In the literature, there are a limited number of studies reporting data concerning dose area product to patients
undergoing abdominal stent-graft implantation. None of these papers report speciﬁc organ doses. In this paper,
absorbed radiation doses in selected organs and cancer/mortality risks were estimated. In particular age, gender,
and anatomical parameters of patients’ aneurysms and arteries were considered. CALDose_X software was
used, which improves on earlier software tools, which were mostly based on mathematical MIRD5-type
phantoms.Objectives and design: The aim of this work was to assess absorbed radiation doses in selected organs and to
estimate cancer and mortality risks in patients undergoing abdominal stent-graft implantation, as a function of
age, gender, and anatomical parameters of patients’ aneurysms and arteries.
Materials and methods: 297 patients (266 males and 31 females) underwent endovascular aortic aneurysm
repair (EVAR) with abdominal stent-graft implantation. Kermaearea products Gy-cm2 for all implanted patients
were collected retrospectively. Entrance surface air kerma (ESAK), doses absorbed by selected organs, and
cancer/mortality risks were estimated using Monte Carlo simulation methods (CALDose_X software).
Results: The highest radiation doses were deposited in the skin, gallbladder wall, and colon wall. The highest
average cancer risk was found for the youngest group of patients (<60 years old; 1:275) and the lowest for the
oldest (>70 years old, 1:735). The radiation-induced risk of cancer mortality (mortality risk) was about 40% lower
than radiation-induced cancer occurrence risk. Aneurysm neck angulations >45 had a signiﬁcant impact on
ESAK, as well as increasing cancer and mortality risks.
Conclusions: The main factors increasing cancer risk are young age and aneurysm neck angulations >45, which
determines the difﬁculty of proper stent-graft placement. However, the radiation risk associated with the stent-
graft implantation procedure is relatively low, and EVAR should not be avoided.
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aneurysm repair (EVAR)INTRODUCTION
Endovascular aortic aneurysm repair (EVAR) was introduced
as an alternative to open repair for the treatment of aortic
aneurysms.1,2 It is less invasive than a surgical procedure
and is widely used. In general, stent-grafting involves lower
risks of complications and shorter hospital recuperation
than traditional surgical operations in cases of pre-existing
neurological, cardiovascular, pulmonary, or renal dysfunc-
tion. However, stent-graft implantation is a radiologicalrresponding author. M.A. Blaszak, Adam Mickiewicz University, Fac-
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//dx.doi.org/10.1016/j.ejvs.2014.03.014procedure that delivers relatively high radiation doses3e8
(Table 1).
The procedure may be coupled with extended exposure
to X-rays for intervention planning, and manipulation of
catheters and endovascular devices, as well as for long-term
postoperative surveillance.9 Concern has been expressed
regarding the radiation risks to both the patient and oper-
ator for ﬂuoroscopically based interventional
procedures.10,11
The radiation dose, as the doseearea product or effective
dose, associated with abdominal aortic stent-graft implan-
tation is documented in only a few papers. None of them
considers speciﬁc organ radiation doses for patients un-
dergoing such a procedure.
X-ray examinations expose the human body to variable
amounts of radiation. Depending on its location with
respect to the boundaries of the irradiated body volume, a
Table 1. Fluoroscopy time and DAP related to aneurysm repair.
Number
of
patients
Mean
ﬂuoroscopy
time (min)
Mean (median)
DAP (Gy-cm2)
Kalef-Ezra et al., 2009 62 23 42.5 (37.4)
Jones, et al., 2010 320 29 47 (no data)
Blaszak, et al., 2009 61 23 381 (355)
Geijer, et al., 2005 24 28 72 (60.1)
Panuccio, et al., 2011 47 83 782 (697)
24 M.A. Blaszak and R. Juszkatspeciﬁc organ or tissue can be exposed to primary radiation
completely, partly, or not at all. Moreover, the long-term
outcomes after endovascular repair are not as well docu-
mented as the long-term outcomes after open repair. In
particular, the exact cancer and mortality risks associated
with such treatments should be evaluated.
Practical dosimetric quantities such as ESAK (entrance
surface air kerma; the kerma in air on the X-ray beam axis at
the patient’s skin) and KAP (air kermaearea product; the
integral of air kerma across the entire X-ray beam emitted
from the X-ray tube) are normally used to set absorbed
doses and can be used as a means of risk assessment.12e15
The average dose to organs and tissues, as well as the
cancer and mortality risks, can easily be assessed in virtual
human phantoms using Monte Carlo (MC) methods.
MC simulation has become an accepted technique for
solving radiation transport problems in many applications,
including medical physics. CALDose_X (Department of Nu-
clear Energy, Federal University of Pernambuco, Recife,
Brazil) is a software tool that assesses doses absorbed by
organs and tissues of the human body and the associated
cancer and mortality risks for radiographic examinations (an
alternative to the effective dose, which cannot be used for
an individual patient).16,17 The tissue-weighting factors
applied in the calculation of the effective dose are calcu-
lated as gender- and age-averaged values and therefore
effective dose cannot be used for the assessment of indi-
vidual risk.18 Thus, the concept of effective dose for patients
exposed to ionizing radiation from radiological procedures
was not used in this study. Instead, the doses absorbed by
selected organs and the cancer and mortality risks for pa-
tients undergoing abdominal stent-graft implantation as a
function of gender, age, and anatomical parameters of an-
eurysms and arteries were calculated. CALDose_X improves
on earlier software tools, which were mostly based on
mathematical MIRD5-type phantoms, by using a less
representative human anatomy.16
MATERIALS AND METHODS
Study design
In this study, measurements of KAP were simultaneously
carried out from May 2006 to January 2013 on a sample of
297 adult patients (266 males and 31 females; 9% <60
years; 29% 61e70 years; 62% >70 years), who underwent
abdominal stent-graft implantation. KAP, Gy-cm2, for all
implanted patients were collected retrospectively, and
hence ethical approval was not required. Additionally,aneurysm neck angulation (in degrees; the angle formed
between the ﬂow axes of the neck and body of the aneu-
rysm) and the occurrence of iliac tortuosity were assessed
(on the basis of CT performed before stent-graft implanta-
tion) in 93 patients (from May 2006 to January 2009) to
determine whether either of these parameters affects ra-
diation risks. All radiation data were analyzed retrospec-
tively on the basis of archived information.
Risk calculations
CALDose_X (Department of Nuclear Energy, Federal Uni-
versity of Pernambuco, Recife, Brazil) is a Monte Carlo
software tool that assesses doses absorbed by organs and
tissues of the human body and the associated cancer and
mortality risks for radiographic examinations (an alternative
to the effective dose, which cannot be used for an indi-
vidual patient).16,17 The tissue-weighting factors applied in
the calculation of the effective dose are calculated as
gender- and age-averaged values, and therefore effective
dose cannot be used for the assessment of individual risk.18
Thus, the concept of effective dose for patients exposed to
ionizing radiation from radiological procedures was not
used in this study. Instead, the doses absorbed by selected
organs and the cancer and mortality risks for patients un-
dergoing abdominal stent-graft implantation as a function
of gender, age, and anatomical parameters of aneurysms
and arteries were calculated. CALDose_X improves on
earlier software tools, which were mostly based on math-
ematical MIRD5-type phantoms, by using a less represen-
tative human anatomy.16
The absorbed dose can be deﬁned by the ratio E:m,
where E is the energy absorbed by the medium as a result
of a beam of ionizing radiation being directed at a small
mass, m. In X-ray examinations, the absorbed dose is the
same as the equivalent dose (Gy). The absorbed dose in
selected organs (mGy), ESAK, as well as cancer and mor-
tality risks for average-sized male and female patients were
calculated using CALDose_X. This program uses conversion
coefﬁcients (CCs) that were calculated using MASH (Male
Adult meSH) and FASH (Female Adult meSH) human
phantoms. Twenty-four different X-ray examinations with
various projections can be simulated using spectra with
2.0e5.0 mm Al ﬁltration between 60 and 150 kVp and
different focus-to-detector distances (FDD). CALDose_X
calculates CCs between organ and tissue absorbed doses,
and also cancer incidence and mortality risks per kerma
area product for the age deﬁned by the user. An area of skin
(7.2  7.2 cm), centred on the central axis of the X-ray
beam, was used to calculate the entrance skin absorbed
dose. The doses absorbed by the red bone marrow (RBM)
and the bone surface cells (BSC) were calculated for those
bones located inside the beam volume that showed the
greatest values for such skeletal tissues. The cancer risks
were calculated as “whole body effective risk”, which is the
sum of risk-weighted organ absorbed doses using the risk
factors given in the BEIR VII report.19 MC simulations were
performed at appropriate peak potential (usually between
80 kVp and 90 kVp), actual beam ﬁltration, focus-to-
Table 2. Radiation doses absorbed by organs and tissues in
patients anatomically similar to the Male Adult meSH (MASH)
and the Female Adult meSH (FASH) phantoms categorised by
gender.
Absorbed dose (SE) [mGy] p (Manne
Whitney test)Male Female
ESAK 517 (24) 374 (40) .02
Adrenals 23.4 (1) 28.2 (3.2) .11
Bladder wall 79 (3.6) 89 (9.9) .25
Colon wall 180 (8.2) 142 (15.8) .08
Breasts, glandular e 5.9 (0.7) e
Kidneys 38.4 (1.7) 31.9 (3.7) .20
Liver 114 (5.2) 89.4 (10.2) .11
Lungs 3.7 (0.2) 4.6 (0.5) .04
Oesophagus 4.2 (0.2) 5 (0.6) .14
Testes/ovaries 7.7 (0.4) 80 (9.2) e
Pancreas 162 (7.4) 97 (11.1) .0003
Small intestine wall 174 (8) 134 (15.4) .08
Skin entrance
7.2 cm  7.2 cm
537 (25) 380 (43) .02
Spleen 68.4 (3.1) 64.3 (7.4) .80
Stomach wall 177 (8.1) 118 (13.5) .004
Prostate 27.4 (1.2) e e
Uterus e 60.5 (7) e
Heart wall 4.7 (0.2) 6 (0.7) .05
Lymphatic nodes 72 (3.3) 68.5 (7.9) .90
Gallbladder wall 299 (13.7) 183 (21) .0006
Skeleton average 41.6 (1.9) 43.8 (5.1) .52
Maximum RBM
absorbed dose
41 (1.9) 39.9 (4.6) .98
Maximum BSC
absorbed dose
53 (2.4) 52 (6.1) .98
Weighted
MASH/FASH dose
63 (2.9) 55 (6.3) .41
RBM ¼ red bone marrow; BSC ¼ bone surface cells.
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position. Imaging was anterioreposterior (AP). The MC
calculations were performed with 5 million source photons
per examination.
Operative technique
All clinical procedures were performed with an operating C-
arm unit (Allura, Philips Medical Systems, Best, The
Netherlands) using pulsating X-ray radiation. COOK and
GORE stent-graft were used. To prevent unexpected com-
plications and to reduce unnecessary radiation exposure,
accurate three-dimensional computed tomography was
used before stent-graft implantation.
Stent-grafts (SGs) were implanted in conventional fashion
from the right side with contra limb cannulation from the
left to complete the procedure. Access was by open cut-
down technique.
Statistical analysis
Results were analysed using the ManneWhitney and
KruskaleWallis tests, according to subgroups based on
gender, age, aneurysm neck angulation (in degrees), and
occurrence of iliac tortuosity. A p value <.05 was consid-
ered signiﬁcant.
RESULTS
The mean KAP was 271 Gy-cm2 in males (range 37e
1760 Gy-cm2) and 276 Gy-cm2 in females (range 64e
625 Gy-cm2). The mean ESAK was 517 mGy for males (range
68e3219 mGy) and 374 mGy for females (range 39e
1109 mGy). In 32% of patients ESAK was between 0.5 Gy
and 1 Gy, and in 7% of patients, it exceeded 1 Gy (with a
maximum observed value of 3.2 Gy). Absorbed doses for all
radiated organs categorised by gender are shown in Table 2.
The highest mean radiation doses were deposited in the
skin (537 mGy in males, 380 mGy in females), gallbladder
wall (299 mGy in males, 183 mGy in females), and colon
wall (180 mGy in males, 142 mGy in females). There were
signiﬁcant differences between males and females for colon
wall, lungs, pancreas, skin entrance, stomach, and gall-
bladder wall.
Cancer incidence and mortality risk per 100,000 cases are
presented in Fig. 1. Despite lower risk coefﬁcients for the
gender-speciﬁc organs in males, the difference in cancer risk
between male and female patients was statistically insig-
niﬁcant (U ¼ 3416, p ¼ .13; ManneWhitney test). The
highest mean cancer risk was found for the youngest group
of patients (<60 years old) and was 364 per 100,000 cases
(1:275) and the lowest, 136 per 100,000 cases, for patients
>70 years old (1:735) (Fig. 1). The differences between all
age groups were highly signiﬁcant (H ¼ 62.6, df ¼ 2,
p < .00001; KruskaleWallis test). The highest observed
cancer risk (1:66) was found for a 58-year-old male patient
in whom the deposed entrance surface air kerma was
2599 mGy-cm2. In general, mortality risks for both genders
were about 40% lower than cancer risks and with aging, risk
coefﬁcients decreased signiﬁcantly (H ¼ 36.4, df ¼ 2,p < .00001; KruskaleWallis test). The calculations showed
that aneurysm neck angulations >45 have a signiﬁcant
impact on cancer and mortality risk (H ¼ 6.5, df ¼ 2,
p ¼ .04, H ¼ 6.8, df ¼ 2, p ¼ .04, respectively; Kruskale
Wallis test) (Fig. 1). The occurrence of iliac tortuosity had no
inﬂuence on cancer and mortality risks (U ¼ 417, p ¼ .16;
U ¼ 395, p ¼ .10, respectively; ManneWhitney test).DISCUSSION
Large surveys of radiation doses in patients undergoing X-ray
examinations in diagnostic and interventional radiology are
one method adopted by countries or regions with the aim of
reviewing and recommending diagnostic reference levels. For
this reason, the study of radiation doses that patients receive
during various (especially long-lasting) procedures is highly
important.The available data suggest that radiation exposure
during endovascular aneurysm repair might be high.20,21 All
patients should bemonitored for 3months post-procedurally
to look for the appearance of radiation sickness (e.g. multiple
blood tests, and clinical interview).
Diseases such as arterial stenosis or high blood pressure
necessitate higher doses of ionic radiation, causing prob-
lems with the positioning and deployment of the
prosthesis.21
Figure 1. The radiation-induced risk of cancer mortality (mortality risk) and cancer incidence as a function of gender, age, occurrence of iliac
tortuosity, and aneurysm neck angulations.
26 M.A. Blaszak and R. JuszkatThe time required for stent-graft implantation is inﬂu-
enced by the anatomy of the aorta and iliac arteries. For
example, it is sometimes difﬁcult and time-consuming to
deliver the stent-graft safely through a tortuous iliac artery.
The correct location of the stent-graft requires precision
and may prolong the length of the operation e inﬂuencing
the radiation dose. This study has shown that angulations
exceeding 45 require more precise implantation of the
main body of the graft. Moreover, this requires more an-
gulations of the image intensiﬁer and contributes to a
greater overall dose of radiation.In the literature, there are a limited number of studies
reporting data concerning KAP (or DAP) in such pro-
cedures. For those which are available, the spread of the
DAP values is very large and none report speciﬁc organ
doses. Kalef-Ezra et al.9 have reported mean DAP values
ranging from 30 to 782 Gy cm2 (which is two times higher
than the value presented here). A trigger level of
300 Gy cm2 was proposed by Neofotistou.22 This value, in
the case of complex procedures such as stent-graft im-
plantation, is exceeded in more than 35% of cases (in our
study).
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divided into stochastic and deterministic effects. Stochastic
effects are chance events, with the probability of the effect
increasing with dose, but the severity of the effect is in-
dependent of the dose received (genetic risks in offspring or
somatic effects like cancer). Deterministic effects are
related directly to the absorbed radiation dose and the
intensity of the effect increases as the dose increases.
Deterministic effects have a threshold below which the
effect does not occur and are based on tissue damage.
The probability of induction of stochastic effects is
related to the weighted sum of the doses absorbed in
various organs and tissues speciﬁed by ICRP.18 Our simula-
tions showed that the mean cancer risk associated with
stent-graft implantation is relatively low (average: 136e364
per 100,000 cases). It is related to the fact that most EVAR
patients are above the age of 65 (age-related risk co-
efﬁcients decrease with aging), and deterministic injuries
are usually of greater concern than those of stochastic ef-
fects. It has been shown that the highest mean cancer risk
was found for the youngest group of patients and with
aging, risk coefﬁcients decreased signiﬁcantly. The highest
observed cancer risk (1:66) was found for a 58-year-old
male patient in whom the deposed entrance surface air
kerma was 2599 mGy-cm2. Therefore, radiation-induced
cancer risks in the young also constitute a potential
contra-indication to EVAR in this group.
The fact that complications of endovascular therapy can
occur early or be delayed means that life-long imaging
follow-up is required. Typical follow-up imaging manage-
ment consists of a CT examination performed within the
ﬁrst month after stent-graft placement. As complications
such as endoleak, aneurysm sac expansion, and graft
migration may occur long after the stent-graft is placed,
imaging surveillance must be lifelong.23,24 In this work the
cancer and mortality risks associated only with the
completed operation were calculated. The total cancer risk
will be slightly greater overall, and will depend on the total
radiation dose that the patient receives, including the pe-
riodic assessments after stent-graft implantation. Moreover,
it should be noted that the cancer risk for patients depends
on various factors, such as a number of equipment-related
variables including beam collimation, servicing, ﬁlter usage,
movement capabilities of the X-ray source, ﬂuoroscopic
speciﬁcations (pulse rate, acquisition frame rate, and
acquisition input dose rates), the position of the projection
and potential variations in the skill of the operator.25
EVAR might be accomplished in an operating theatre
using a mobile C-arm for X-ray guidance or in a dedicated
angiographic suite using ﬁxed equipment. It was thought
that the mobile C-arm might lead to higher patient doses
because of greater operational difﬁculties and higher staff
doses as it produces a less focused beam with a wider
scatter of X-rays, compared with dedicated angiographic
equipment.4 On the other hand, Fossaceca et al.26
demonstrated that EVAR performed using a ﬂuoroscopy C-
arm resulted in a very low patient radiation dose. The pa-
tient’s radiation dose increases by at least one order ofmagnitude when using mobile or ﬁxed angiographic
equipment, whereas the clinical outcomes are equivalent.
Further studies from other research centres (ideally using
different machinery and other operators) are required to
verify these ﬁndings.Conclusions
This study determined radiation doses in selected organs
and estimated cancer and mortality risks using Monte Carlo
methods in patients undergoing abdominal stent-graft im-
plantation as a function of age, gender, and anatomical
parameters of patients’ aneurysms and arteries.
Consequently, the X-ray doses absorbed by speciﬁc or-
gans and the associated cancer risk are not very high, but
are signiﬁcant. It has been shown that average cancer risk
ranges from 364 per 100,000 cases (1:275) in the youngest
patients (<60 years) to 136 per 100,000 cases (1:735) in the
oldest (>70 years). The main factors increasing cancer risk
are young age and aneurysm neck angulations >45, which
determines the difﬁculty of proper stent-graft placement.
However, the radiation risk associated with the stent-graft
implantation procedure is relatively low, thus even in
these cases EVAR should not be avoided.
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